Security Snapshot

Hims & Hers Health Inc - Common Stock (HIMS) Institutional Ownership

CUSIP: 433000106

13F Institutional Holders and Ownership History from Q1 2020 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

507

Shares (Excl. Options)

155.89MFull value: 155,892,746 · shares · 30 Jun 2026

Price

$34.67

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
HIMS on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
155,892,746
Latest holder snapshot 5 signals
Total 13F value
$5,390,972,793
Portfolio coverage rank
0.01%
Share change
+6,946,749
Value change
+$438,829,251
Number of holders
507
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
225,153,219
SEC-reported price per share
$29.79
Insider filing price
$29.79
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • HIMS - Hims & Hers Health Inc - Common Stock is tracked under CUSIP 433000106.
  • 507 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 434 to 507 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $3.08BFull value: $3,079,386,491 · USD · 31 Mar 2026
    to
    $5.39BFull value: $5,390,972,793 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 507 institutions filings for Q2 2026.

Open SEC evidence

Security key

433000106

13F reference period

Q2 2026

13F holders

507

13D/G owners

6

CIK / CUSIP context first

Open Q2 2026 holders HIMS full holder history Hims & Hers Health, Inc. SEC filings Hims & Hers Health, Inc. company facts Hims & Hers Health, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
HIMS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% +10% $918,623,878 +$119,582,065 26,496,218 +15% BlackRock, Inc. 30 Jun 2026
Dudum Andrew 9.4% -9% $650,489,758 -$34,837,679 22,610,002 -5.1% Andrew Dudum 27 Aug 2026
SUSQUEHANNA SECURITIES, LLC 6.5% $306,725,654 14,502,395 G1 Execution Services, LLC 31 Mar 2026
Capital World Investors 6.5% -23% $461,197,766 -$136,411,758 14,322,912 -23% Capital World Investors 31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC 5% -0.8% $333,353,526 +$38,965 11,190,115 +0.01% Vanguard Capital Management 30 Sep 2026
JPMORGAN CHASE & CO 1.7% -80% $61,332,282 -$219,856,510 3,881,790 -78% JPMORGAN CHASE & CO. 27 Feb 2026
As of 30 Jun 2026, 507 institutional investors reported holding
155.89MFull value: 155,892,746 · shares · 30 Jun 2026
shares of Hims & Hers Health Inc - Common Stock (HIMS). This represents 69% of the company’s total
225.15MFull value: 225,153,219 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
52%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 28,703,514 +9% 0.01% $995,150,830
VANGUARD PORTFOLIO MANAGEMENT LLC 4.7% 10,559,314 +3.7% 0.02% $366,091,416
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 9,541,384 +2.2% 0.01% $330,799,783
STATE STREET CORP 3.6% 8,145,699 +9.2% 0.01% $282,411,384
MORGAN STANLEY 3.2% 7,152,498 -20% 0.01% $247,977,138
Divisadero Street Capital Management, LP 2.7% 6,009,505 +1179% 4.9% $208,349,538
GEODE CAPITAL MANAGEMENT, LLC 2.5% 5,681,832 +9.3% 0.01% $197,024,228
GOLDMAN SACHS GROUP INC 2.3% 5,173,865 +111% 0.02% $179,377,886
JPMORGAN CHASE & CO 2.1% 4,766,781 -9% 0.01% $159,475,865
FMR LLC 1.9% 4,323,292 +4535% 0.01% $149,888,528
MARSHALL WACE, LLP 1.9% 4,217,767 +482% 0.12% $146,229,983
UBS Group AG 1.2% 2,660,810 -36% 0.01% $92,250,283
NORTHERN TRUST CORP 1.2% 2,594,277 +6.5% 0.01% $89,943,583
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 2,453,787 +4% 0.01% $85,072,795
STATE OF MICHIGAN RETIREMENT SYSTEM 1% 2,346,282 +0.33% 0.36% $81,345,597
BANK OF AMERICA CORP /DE/ 1% 2,312,272 -47% 0.01% $80,166,472
PRINCIPAL FINANCIAL GROUP INC 0.74% 1,667,073 +30% 0.03% $57,797,421
VANGUARD FIDUCIARY TRUST CO 0.68% 1,522,249 +5% 0.01% $52,776,373
Bank of New York Mellon Corp 0.59% 1,333,146 -0.54% 0.01% $46,220,159
SCHRODER INVESTMENT MANAGEMENT GROUP 0.5% 1,129,781 +54% 0.03% $37,723,388
FRANKLIN RESOURCES INC 0.46% 1,032,639 +740% 0.01% $35,801,594
JANE STREET GROUP, LLC 0.44% 1,000,484 +317% 0.02% $34,686,780
Clear Street Group Inc. 0.44% 989,913 -24% 0.11% $34,320,284
Marex Group Ltd 0.43% 973,771 -27% 0.25% $33,760,641
PRICE T ROWE ASSOCIATES INC /MD/ 0.41% 932,220 -34% 0% $32,321,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
26
Headline period
Q2 2026
Rows shown
1-25 of 26
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 4,025,736 $119,908,076 -$40,421,158 $29.79 108
2026 Q2 155,892,746 $5,390,972,793 +$438,829,251 $34.67 507
2026 Q1 148,873,273 $3,079,386,491 -$910,513,563 $20.76 434
2025 Q4 183,339,602 $5,958,165,218 -$669,117,583 $32.47 486
2025 Q3 199,883,212 $11,335,508,253 +$1,437,053,454 $56.72 508
2025 Q2 175,272,401 $8,737,551,983 +$961,576,555 $49.85 501
2025 Q1 156,499,038 $4,623,681,560 -$176,903,936 $29.55 418
2024 Q4 164,535,250 $3,980,113,570 +$662,356,870 $24.18 385
2024 Q3 137,388,700 $2,532,982,313 +$13,483,116 $18.42 302
2024 Q2 135,555,935 $2,737,194,047 +$237,895,932 $20.19 291
2024 Q1 127,014,197 $1,964,665,169 +$120,987,021 $15.47 236
2023 Q4 124,812,595 $1,110,858,696 -$20,511,047 $8.90 194
2023 Q3 119,054,225 $748,816,065 -$112,963,918 $6.29 189
2023 Q2 132,438,140 $1,244,975,489 +$139,460,952 $9.40 185
2023 Q1 119,222,566 $1,182,050,601 +$138,780,557 $9.92 185
2022 Q4 105,528,105 $676,436,778 +$198,928,135 $6.41 151
2022 Q3 94,761,647 $528,756,939 +$31,959,823 $5.58 145
2022 Q2 89,005,896 $403,186,006 +$45,235,978 $4.53 132
2022 Q1 78,422,127 $417,949,018 -$13,253,687 $5.33 127
2021 Q4 70,024,982 $458,628,840 +$14,988,392 $6.55 137
2021 Q3 42,323,200 $319,091,740 -$102,457,566 $7.54 107
2021 Q2 54,478,149 $592,933,897 +$19,733,325 $10.89 84
2021 Q1 52,489,763 $692,968,615 +$689,881,615 $13.23 80
2020 Q4 186,615 $2,725,000 +$2,725,000 $14.60 1
2020 Q3 0 $0 -$53,000 $29.79 0
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .